Quantcast
US Market Closed
Oct 17,2018
NIKKEI 225  22658.16
-182.96 ▼-0.8%
OMXN40  1472.47
2 ▼0.14%
FTSE100  6859.15
-34.77 ▼-0.5%

Stock Market Overview

Index Value Change Net / %
Data as of Oct 17, 2018
 


Stock Market News & Analysis


Stock Activity

Company Last Sale* Change Net / % Share Volume
$10.20 1.11 ▲ 12.21% 88,683,851
$27.30 0.88 ▼ 3.12% 86,883,607
$177.29 0.07 ▲ 0.04% 62,890,173
$12.53 0.06 ▼ 0.48% 42,040,755
$364.70 18.30 ▲ 5.28% 31,268,645
As of 10/17/2018 4:00:00 PM

Company Last Sale* Change Net / % Share Volume
$3.66 0.81 ▲ 28.42% 14,095,126
$3.45 0.71 ▲ 25.91% 2,555,471
$2.18 0.38 ▲ 21.11% 345,194
$2.76 0.47 ▲ 20.52% 2,215,282
$2.18 0.30 ▲ 15.96% 672,724
As of 10/17/2018 4:00:00 PM

Company Last Sale* Change Net / % Share Volume
$3.065 0.76 ▼ 19.76% 2,905,896
$2.885 0.61 ▼ 17.34% 612,644
$15.01 3.11 ▼ 17.16% 2,474,365
$8.75 1.25 ▼ 12.50% 6,116
$60.54 8.34 ▼ 12.11% 3,826,687
As of 10/17/2018 4:00:00 PM

Company Last Sale* Change Net / % Share Volume
$177.29 0.07 ▲ 0.04% 66,902,278
$364.70 18.30 ▲ 5.28% 32,512,994
$1,831.73 11.77 ▲ 0.65% 5,272,397
$221.19 0.96 ▼ 0.43% 22,576,532
$110.71 0.29 ▼ 0.26% 25,696,951
As of 10/17/2018 4:00:00 PM

Company Last Sale Price Change Net / % Share Volume Volume % Change
$10.20 8.677 ▲ 569.69% 35,936,134 50463%
$10.20 1.11 ▲ 12.21% 89,193,583 561%
$33.20 1.45 ▲ 4.57% 3,570,658 530%
$56.64 1.63 ▲ 2.96% 2,615,649 485%
$28.74 .60 ▲ 2.13% 533,182 342%
As of 10/17/2018 4:15:00 PM

Upcoming IPOs

Name Price Range
TWIST BIOSCIENCE CORP $14.00 - $16.00
ETON PHARMACEUTICALS, $6.00
STONECO LTD. $21.00 - $23.00

Earnings

Earnings Calendar

Visit Earnings Calendar for the week starting 10/14; 101 reports are scheduled.

Company Last Sale* Change Net / %
PM$84.561.06 ▲ 1.27%

Recommendations

Forecasts

Surprises


ETFs

Decliners

Advancers


Today at Nasdaq







Market Musings

Martin Tillier's daily read on the markets.

Martin Tillier

The Week in ETFs

A weekly briefing on major news, trends and players shaping the world of ETFs.



Investing Ideas

Richard Saintvilus offers actionable investing insights.

x